United States · FDA National Drug Code directory
Medroxyprogesterone Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0548-5701_8ef1da8b-5fce-4375-9186-39f75adc4f1b
- Product NDC
- 0548-5701
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Medroxyprogesterone acetate
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171128
- Source listing expiry
- 20271231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0548-5701-00) / 1 mL in 1 SYRINGE · 0548-5701-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →